DOXGX | PNBAX | DOXGX / PNBAX | |
Total Expense Ratio | 0.41 | 1.00 | 41% |
Annual Report Gross Expense Ratio | 0.46 | 1.00 | 46% |
Fund Existence | 3 years | 23 years | - |
Gain YTD | 3.684 | -0.418 | -881% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 114B | 269M | 42,379% |
Annual Yield % from dividends | 1.49 | 1.31 | 114% |
Returns for 1 year | 6.03 | 4.30 | 140% |
Returns for 3 years | 28.44 | -1.98 | -1,435% |
Returns for 5 years | N/A | 17.75 | - |
Returns for 10 years | N/A | 37.90 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GAAHX | 18.60 | 0.40 | +2.20% |
GMO Resources R6 | |||
CZMVX | 15.94 | -0.15 | -0.93% |
Multi-Manager Value Strategies Inst | |||
GMVIX | 15.85 | -0.24 | -1.49% |
Goldman Sachs Small/Mid Cap Value Inv | |||
LTAGX | 15.65 | -0.24 | -1.51% |
Lord Abbett International Growth R5 | |||
CECYX | 26.75 | -1.17 | -4.19% |
Columbia Large Cap Enhanced Core Inst3 |